Latest Strategic Investment News

Biome Australia Limited has reported a robust half-year performance, with revenues climbing nearly 40% and net profit more than doubling, driven by strong product momentum and strategic investments.

GenusPlus Group Ltd has reported a record half-year with a 61% jump in revenue to $535.4 million and an 82% rise in net profit to $24.9 million, driven by strong performance across all business segments and strategic acquisitions. The company also declared its first-ever fully franked interim dividend of 2.0 cents per share.

Legend Mining has received an $811,458 cash refund from the Australian Taxation Office for its FY2025 R&D claim, lifting its cash position to nearly $11 million.

McMillan Shakespeare Limited reported a 9.7% rise in statutory net profit for the first half of FY26, driven by strong revenue growth and productivity gains. The company declared a fully franked 62 cent dividend and announced a $10 million on-market share buyback.

Forrestania Resources has contracted Como Engineers to deliver a fully automated modular gold processing plant for its Lake Johnston facility, marking a key step towards production. The $5.57 million plant will be pre-assembled and hot tested to streamline commissioning.

Imperial Pacific Limited reported a half-year net profit of $148,000 for the six months ending December 2025, supported by strong asset growth and a fully franked 7 cent dividend. The company’s portfolio, including stakes in London City Equities and Excelsior Capital, drove net asset value to record highs despite a dip in profit.

PolyNovo Limited reported a robust 25.2% increase in half-year revenue to A$75 million, driven by strong U.S. sales and product growth, despite a near break-even net profit impacted by a manufacturing slowdown and a fire at its R&D lab.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing for its lead ophthalmology product, Elate Ocular®, alongside key global partnerships and a $2.4 million capital injection from a major shareholder.

Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.

BSP Financial Group has reported a robust 12.9% increase in net profit for 2025, underpinned by strong revenue growth and strategic restructuring, including converting its Fiji branch into a wholly owned subsidiary.

Latitude Group Holdings Limited reported a robust 59% increase in Cash NPAT for FY25, driven by strong volume growth and margin expansion, while declaring a fully franked 9.00 cents per share dividend.

Peter Warren Automotive Holdings reported a 3.2% revenue increase to $1.268 billion and more than doubled its profit after tax to $7.435 million in the first half of FY26, declaring a fully franked interim dividend of 3.0 cents per share.